
European Journal of Medicinal Chemistry p. 90 - 101 (2012)
Update date:2022-07-29
Topics:
García, Gonzalo
Serrano, Isabel
Sánchez-Alonso, Patricia
Rodríguez-Puyol, Manuel
Alajarín, Ramón
Griera, Mercedes
Vaquero, Juan J.
Rodríguez-Puyol, Diego
álvarez-Builla, Julio
Díez-Marqués, María L.
We report new examples of a series of losartan-hydrocaffeic hybrids that bear novel ester, amide and amine linkers. These compounds were made by linking hydrocaffeic acid to the side chain of losartan at the C-5 position of the imidazole ring through different strategies. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect and have increased antioxidant ability. Most of them reduced arterial pressure in rats better or as much as losartan.
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Buffett (China) Holding Co.,Ltd
Contact:4006570891
Address:
Shandong Jincheng Zhonghua Bio-pharmaceutical Co.,Ltd
Contact:+86-533-5415882
Address:Zichuan Economic Development Zone,Zibo City,Shandong Province,China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Nanjing Vincero International Trading Co.,Ltd
Contact:8618936897229
Address:NO.68, ZhuShan Road, JiangNing WanDa Plaza, Building E Room 1703
Doi:10.1016/S0040-4039(00)61918-4
(1985)Doi:10.1021/ja01120a509
(1953)Doi:10.1097/00005537-200211000-00008
(1955)Doi:10.1021/acs.organomet.7b00003
(2017)Doi:10.1021/ja00310a058
(1985)Doi:10.1021/jo302207b
(2012)